| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |